IVX: IVAX Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IVX: IVAX Corporation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (58)	1/12/2005 12:40:20 PM
From: Jim Oravetz	Read Replies (1) of 78

IVAX To Meet Or Exceed Consensus Analysts' Views For 4Q 2004 DOW JONES NEWSWIRES January 11, 2005 1:50 p.m. MIAMI -- Ivax Corp. (IVX) expects its fourth-quarter, per-share earnings to meet or beat the average Wall Street estimate. In a press release Monday, the Miami developer and maker of generic drugs said fourth-quarter earnings will be at least 19 cents a share, which is the average estimate produced by a Thomson First Call survey of 11 analysts. Ivax had net income of 15 cents a share in the year-earlier quarter. The company plans to release fourth-quarter results and 2005 financial guidance in mid-March. Ivax shares recently traded at $14.589, down 221 cents, or 1.54%, on composite-trading volume of 3.95 million shares. Average daily volume is 2.68 million shares. Company Web site: ivax.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next